ArticleInternal medicine (Tokyo, Japan)2022

Study on Continuation of Antibody Prevalence Six Months after Detection of Subclinical Severe Acute Respiratory Syndrome Coronavirus 2 Infections.

Ikuro Matsuba et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.